Clinical Trial Update: Sotevtamab (AB-16B5) Combined With FOLFOX as Neoadjuvant Treatment Prior to Resection of Colorectal Cancer Liver Metastasis [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating Sotevtamab (AB-16B5) in combination with FOLFOX as neoadjuvant therapy before resection of colorectal cancer liver metastases. The st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• FOLFOX
• Sotevtamab (AB-16B5)

Snippet

Sponsor: Alethia Biotherapeutics | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: RECRUITING